MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf ...

Novel combination of acimtamig and an allogenic natural killer cell product shows safety and promising objective response ...

We recently published a list of 15 Stocks That Stole The Show Last Week. In this article, we are going to take a look at ...

Bachleda, PharmD, MBA appointed as independent member of the Board of Directors ; David Shook, MD appointed as Chief Medical Officer, Mark ...

Exercising during chemotherapy and before surgery may help the body send more immune cells into cancerous tumors, according ...

Exercising during chemotherapy and before surgery may help the body send more immune cells into cancerous tumors, according ...

Fifteen companies skyrocketed by double to triple digits last week, buoyed by fresh company-specific developments and a ...

The immunological synapse can be defined as the orderly rearrangement of molecules in an immune cell at the interface with another cell. In natural killer (NK) cells, the lytic immunological ...

Sit under a tree during your lunch break and allow your eyes to look into the vastness far in front of you. Practise yoga or ...

In developing this automated cell therapy processing platform, Limula’s founders aim to create a disruptive production ...

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat ...